Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Solaredge Technologies Inc (SEDG) vs GeneDx Holdings Corp (WGS) Price & Performance

Solaredge Technologies IncTrade
GeneDx Holdings CorpTrade

Price performance (Past 24H)

Key statistics

Solaredge Technologies Inc vs GeneDx Holdings Corp — how do they compare? Solaredge Technologies Inc trades at $31.85 (market cap $2.00B), while GeneDx Holdings Corp trades at $67.75 (market cap $2.02B). The key difference: Solaredge Technologies Inc and GeneDx Holdings Corp are close in size by market cap, and GeneDx Holdings Corp is trading nearer its 52-week high, Solaredge Technologies Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Solaredge Technologies Inc for 34 Days and GeneDx Holdings Corp for 19 Days on average.

SEDGWGS
Market Cap
$2.00B$2.02B
Volume
2,739,860734,640
Sector
EnergyHealth
52-Week High
$78.51$167.51
52-Week Low
$28.47$34.51
Typical Hold Time
34 Days19 Days
Enterprise Value
$1.86B$2.05B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Solaredge Technologies Inc

SolarEdge Technologies (SEDG) trades at $33.16, down 2.59% on the day, amid a bearish technical signal and mixed earnings history. The company reported a net loss of $405.45 million in 2025, with a negative net margin of -34.24%, though revenue improved to $1.18 billion. Recent news highlights an ongoing fraud investigation by Pomerantz Law Firm and ambitious long-term revenue targets of $2.4 billion by 2029, alongside new AI data center initiatives developed with NVIDIA.

The outlook remains challenging due to persistent losses and high debt, but analyst consensus suggests modest upside with a $37.75 price target. Key risks include execution on growth targets, competitive pressures, and macroeconomic headwinds affecting solar project financing. Institutional sentiment is cautious, with 56.25% hold ratings.

GeneDx Holdings Corp

GeneDx (WGS) trades at $68.50, down 0.04% with a bearish technical signal despite bullish oscillators showing oversold conditions. The company reported mixed Q2 2026 results with revenue of $114.4M beating expectations but net income margin remains negative at -23.4%. Recent developments include new product launches and positive analyst coverage with 91% buy ratings.

While analyst consensus targets $81.00 (18% upside), fundamental challenges persist with negative profitability metrics and high valuation multiples. The stock faces execution risks amid competitive genomics landscape, but operational improvements and testing volume growth provide potential catalysts for recovery.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

SEDG
58% Buy42% Sell
Avg holding period · 34 Days
WGS
53% Buy47% Sell
Avg holding period · 19 Days

Top news

Latest headlines on both assets

About Solaredge Technologies Inc

SolarEdge Technologies designs, develops, and sells direct current optimized inverter systems for solar photovoltaic installations. The company system consists of power optimizers, inverters, and cloud-based monitoring platform and addresses a broad range of solar market segments, from residential solar installations to commercial and small utility-scale solar installations. The company sells its products directly to solar installers, engineering, procurement, and construction firms and indirectly to solar installers through distributors and electrical equipment wholesalers. Additionally, the company has nonsolar products targeting energy storage and e-mobility.

Read more on SEDG →

About GeneDx Holdings Corp

GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.

Read more on WGS →